While research may appear to take place "behind the scenes" to the average person, at the USA Mitchell Cancer Institute (MCI) it is entirely at the forefront in the fight to find new ways to cure and prevent cancer. Our researchers provide the building blocks for tomorrow's clinical advances through investigation into the mechanisms and pathways involved in the development and progression of cancer.
The mission of the research enterprise at MCI is to discover, develop and deliver innovative solutions that will improve cancer outcomes. To accomplish this mission we are committed to:
Every stride we make to expand hope comes only after an advancement of knowledge. MCI has built a robust, interactive and entrepreneurial training environment where investigators, physicians, physician-scientists, medical students, clinical fellows and Ph.D. graduate students work collaboratively supported by state-of-the-art core laboratories and specialized equipment. Our Research Programs presently include Cancer Biology, Drug Discovery, DNA Repair, and Cancer Cell Death and Metabolism. Shared resources include a biospecimen repository (Biobank), mass spectroscopy and proteomics, advanced microscopy, flow cytometry, and high-throughput, image-based drug discovery. Research is competitively funded through NIH and DOD grants as well as state funds, foundations and endowments. The federal funding base for MCI PI's has significantly increased since occupancy of the new building in 2008.
With the recent addition of new technologies such as the N-SIM and N-STORM super-resolution microscopes, and new initiatives such as our Drug Discovery program and DNA Repair Program, our extraordinary team of scientists and researchers has some of the most advanced tools in the world with which to work. Through this combination of great minds and great technology, we will continue to see new breakthroughs that translate into novel diagnostics for early cancer detection and life-saving treatments for cancer patients.
© 2018 USA Health System